Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Tsangaridou, Elena ^a   Polioudaki, Hara ^a   Sfakianaki, Rania ^a   Samiotaki, Martina ^b   Tzardi, Maria ^a   Koulentaki, Meri ^c   Panayotou, George ^b   Kouroumalis, Elias ^a,c   Castanas, Elias ^a   Theodoropoulos, Panayiotis A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 120 ANTIBODY; LAMIN A; LAMIN B; LAMIN C; PROTEIN P62 ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS MEMBRANE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; RAT; ANIMAL; BILIARY CIRRHOSIS; BLOOD; CELL CULTURE; CLASSIFICATION; EPIDEMIOLOGY; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; VALIDATION STUDY;

ANIMALS; AUTOANTIBODIES; CELLS, CULTURED; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; NUCLEAR ENVELOPE; RATS; SEROEPIDEMIOLOGIC STUDIES;

EID: 77952662018     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-28     Document Type: Article

References (34)

1. Georgatos SD, Theodoropoulos PA. Rules to remodel by: what drives nuclear envelope disassembly and reassembly during mitosis?. Crit Rev Eukaryot Gene Expr 1999, 9:373-81.
2. Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002, 158:915-27. 10.1083/jcb.200206106, 2173148, 12196509.
3. Enarson P, Rattner JB, Ou Y, Miyachi K, Horigome T, Fritzler MJ. Autoantigens of the nuclear pore complex. J Mol Med 2004, 82:423-33. 10.1007/s00109-004-0554-z, 15175862.
4. Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, Rodes J, Dalekos GN, Vergani D. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 2005, 54:528-32. 10.1136/gut.2003.036558, 1774444, 15753539.
5. Wesierska-Gadek J, Penner E, Battezzati PM, Selmi C, Zuin M, Hitchman E, Worman HJ, Gershwin ME, Podda M, Invernizzi P. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006, 43:1135-44. 10.1002/hep.21172, 16628641.
6. Lassoued K, Brenard R, Degos F, Courvalin JC, Andre C, Danon F, Brouet JC, Zine-el-Abidine Y, Degott C, Zafrani S, et al. Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology 1990, 99:181-6.
7. Miyachi K, Hankins RW, Matsushima H, Kikuchi F, Inomata T, Horigome T, Shibata M, Onozuka Y, Ueno Y, Hashimoto E, Hayashi N, Shibuya A, Amaki S, Miyakawa H. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun 2003, 20:247-54. 10.1016/S0896-8411(03)00033-7, 12753810.
8. Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC. Mol Biol Rep 1996, 23:227-34. 10.1007/BF00351173, 9112233.
9. Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D, Bianchi FB. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003, 98:431-7. 10.1111/j.1572-0241.2003.07257.x, 12591064.
10. Wesierska-Gadek J, Hohenuer H, Hitchman E, Penner E. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 1996, 110:840-7. 10.1053/gast.1996.v110.pm8608894, 8608894.
11. Tsiakalou V, Tsangaridou E, Polioudaki H, Nifli AP, Koulentaki M, Akoumianaki T, Kouroumalis E, Castanas E, Theodoropoulos PA. Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence. BMC Immunol 2006, 7:20. 10.1186/1471-2172-7-20, 1574344, 16956395.
12. Courvalin JC, Lassoued K, Bartnik E, Blobel G, Wozniak RW. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest 1990, 86:279-85. 10.1172/JCI114696, 296718, 2195063.
13. Invernizzi P, Podda M, Battezzati PM, Crosignani A, Zuin M, Hitchman E, Maggioni M, Meroni PL, Penner E, Wesierska-Gadek J. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 2001, 34:366-72. 10.1016/S0168-8278(00)00040-4, 11322196.
14. Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, Koyabu M, Yokoyama T, Migita K, et al. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007, 45:118-27. 10.1002/hep.21472, 17187436.
15. Courvalin JC, Lassoued K, Worman HJ, Blobel G. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J Exp Med 1990, 172:961-7. 10.1084/jem.172.3.961, 2188537, 2167346.
16. Nickowitz RE, Worman HJ. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210. J Exp Med 1993, 178:2237-42. 10.1084/jem.178.6.2237, 2191303, 7504063.
17. Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J Exp Med 1995, 182:1159-62. 10.1084/jem.182.4.1159, 2192276, 7561689.
18. Tartakovsky F, Worman HJ. Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope. Hepatology 1995, 21:495-500.
19. Bandin O, Courvalin JC, Poupon R, Dubel L, Homberg JC, Johanet C. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 1996, 23:1020-4. 10.1002/hep.510230512, 8621127.
20. Bauer A, Habior A. Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis. J Clin Lab Anal 2007, 21:227-31. 10.1002/jcla.20170, 17621358.
21. Bogdanos DP, Liaskos C, Pares A, Norman G, Rigopoulou EI, Caballeria L, Dalekos GN, Rodes J, Vergani D. Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology 2007, 45:1583. author reply 1583-4, 10.1002/hep.21678, 17538935.
22. Bogdanos DP, Pares A, Rodes J, Vergani D. Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. Am J Gastroenterol 2004, 99:763-4. author reply 765, 10.1111/j.1572-0241.2004.04119.x, 15089915.
23. Gao L, Tian X, Liu B, Zhang F. The value of antinuclear antibodies in primary biliary cirrhosis. Clin Exp Med 2008, 8:9-15. 10.1007/s10238-008-0150-6, 18385935.
24. Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, Daikoku M, Yano K, Matsumoto T, Migita K, Yatsuhashi H, Ito M, Masaki N, Adachi H, Watanabe Y, Nakamura Y, Saoshiro T, Sodeyama T, Koga M, Shimoda S, Ishibashi H. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol 2005, 42:386-92. 10.1016/j.jhep.2004.11.016, 15710222.
25. Wesierska-Gadek J, Klima A, Komina O, Ranftler C, Invernizzi P, Penner E. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies. Ann N Y Acad Sci 2007, 1109:519-30. 10.1196/annals.1398.058, 17785341.
26. Wesierska-Gadek J, Klima A, Ranftler C, Komina O, Hanover J, Invernizzi P, Penner E. Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen. J Cell Biochem 2008, 104:27-37. 10.1002/jcb.21595, 17960595.
27. Lin F, Noyer CM, Ye Q, Courvalin JC, Worman HJ. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR. Hepatology 1996, 23:57-61. 10.1002/hep.510230109, 8550049.
28. Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 1994, 106:193-9.
29. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996, 335:1570-80. 10.1056/NEJM199611213352107, 8900092.
30. Makatsori D, Kourmouli N, Polioudaki H, Shultz LD, McLean K, Theodoropoulos PA, Singh PB, Georgatos SD. The inner nuclear membrane protein lamin B receptor forms distinct microdomains and links epigenetically marked chromatin to the nuclear envelope. J Biol Chem 2004, 279:25567-73. 10.1074/jbc.M313606200, 15056654.
31. Blobel G, Potter VR. Nuclei from rat liver: isolation method that combines purity with high yield. Science 1966, 154:1662-5. 10.1126/science.154.3757.1662, 5924199.
32. Matunis MJ. Isolation and fractionation of rat liver nuclear envelopes and nuclear pore complexes. Methods 2006, 39:277-83. 10.1016/j.ymeth.2006.06.003, 16870471.
33. Trinkle-Mulcahy L, Boulon S, Lam YW, Urcia R, Boisvert FM, Vandermoere F, Morrice NA, Swift S, Rothbauer U, Leonhardt H, Lamond A. Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J Cell Biol 2008, 183:223-39. 10.1083/jcb.200805092, 2568020, 18936248.
34. Mylonis I, Chachami G, Samiotaki M, Panayotou G, Paraskeva E, Kalousi A, Georgatsou E, Bonanou S, Simos G. Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J Biol Chem 2006, 281:33095-106. 10.1074/jbc.M605058200, 16954218.